Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence.

DOPA decarboxylase (DDC; also known as L-amino acid decarboxylase; AADC) is involved in the synthesis of dopamine, norepinephrine and serotonin. Because the mesolimbic dopaminergic system is implicated in the reinforcing effects of many drugs, including nicotine, the DDC gene is considered a plausible candidate for involvement in the development of vulnerability to nicotine dependence (ND). Further, this gene is located within the 7p11 region that showed a 'suggestive linkage' to ND in our previous genome-wide scan in the Framingham Heart Study population. In the present study, we tested eight single nucleotide polymorphisms (SNPs) within DDC for association with ND, which was assessed by smoking quantity (SQ), the heaviness of smoking index (HSI) and the Fagerstrom test for ND (FTND) score, in a total of 2037 smokers and non-smokers from 602 nuclear families of African- or European-American (AA or EA, respectively) ancestry. Association analysis for individual SNPs using the PBAT-GEE program indicated that SNP rs921451 was significantly associated with two of the three adjusted ND measures in the EA sample (P=0.01-0.04). Haplotype-based association analysis revealed a protective T-G-T-G haplotype for rs921451-rs3735273-rs1451371-rs2060762 in the AA sample, which was significantly associated with all three adjusted ND measures after correction for multiple testing (min Z=-2.78, P=0.006 for HSI). In contrast, we found a high-risk T-G-T-G haplotype for a different SNP combination in the EA sample, rs921451-rs3735273-rs1451371-rs3757472, which showed a significant association after Bonferroni correction with the SQ and FTND score (max Z=2.73, P=0.005 for FTND). In summary, our findings provide the first evidence for the involvement of DDC in the susceptibility to ND and, further, reveal the racial specificity of its impact.

[1]  D. Wang,et al.  Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis , 2005, The Pharmacogenomics Journal.

[2]  Ming D. Li,et al.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. , 2005, American journal of human genetics.

[3]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[4]  A. Clark,et al.  The role of haplotypes in candidate gene studies , 2004, Genetic epidemiology.

[5]  J. Beuten,et al.  Progress in searching for susceptibility loci and genes for smoking‐related behaviour , 2004, Clinical genetics.

[6]  Yan Shen,et al.  No association between polymorphisms in the DDC gene and paranoid schizophrenia in a northern Chinese population , 2004, Psychiatric genetics.

[7]  M. Munafo,et al.  The genetic basis for smoking behavior: a systematic review and meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  Michael Bamshad,et al.  Deconstructing the relationship between genetics and race , 2004, Nature Reviews Genetics.

[9]  Jeffrey H. Meyer,et al.  Smoking-induced ventral striatum dopamine release. , 2004, The American journal of psychiatry.

[10]  D. Nyholt.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[11]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[12]  J. Stephenson.  World health report. , 2004, Lancet.

[13]  Xin Xu,et al.  Family‐based tests for associating haplotypes with general phenotype data: Application to asthma genetics , 2004, Genetic epidemiology.

[14]  Ming D. Li,et al.  A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population , 2003, BMC Genetics.

[15]  H. Feiler,et al.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  M. Picciotto.  Nicotine as a modulator of behavior: beyond the inverted U. , 2003, Trends in pharmacological sciences.

[17]  C. Lerman,et al.  Elucidating the role of genetic factors in smoking behavior and nicotine dependence , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  Christoph Lange,et al.  A multivariate family-based association test using generalized estimating equations: FBAT-GEE. , 2003, Biostatistics.

[19]  N. Risch,et al.  The importance of race and ethnic background in biomedical research and clinical practice. , 2003, The New England journal of medicine.

[20]  D. Collier,et al.  Possible parent‐of‐origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  Thomas A Trikalinos,et al.  Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.

[22]  R. Tyndale,et al.  Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.

[23]  S. Cichon,et al.  Association study between two variants in the DOPA decarboxylase gene in bipolar and unipolar affective disorder. , 2002, American journal of medical genetics.

[24]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[25]  R. Twombly.  World Health Organization takes on 'tobacco epidemic'. , 2002, Journal of the National Cancer Institute.

[26]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[27]  M. Hampson,et al.  Dopa decarboxylase genotypes may influence age at onset of schizophrenia , 2001, Molecular Psychiatry.

[28]  M. Gill,et al.  Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population , 2001, Molecular Psychiatry.

[29]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[30]  J. Hietala,et al.  High levels of dopamine activity in the basal ganglia of cigarette smokers. , 2000, The American journal of psychiatry.

[31]  T. Niu,et al.  Nicotine dependence and its familial aggregation in Chinese. , 2000, International journal of epidemiology.

[32]  E. Perez-stable,et al.  Ethnic differences in N-glucuronidation of nicotine and cotinine. , 1999, The Journal of pharmacology and experimental therapeutics.

[33]  T. G. Bruun,et al.  Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder , 1999, Molecular Psychiatry.

[34]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[35]  A. Boulton,et al.  Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme , 1996, Neurochemical Research.

[36]  G. Chiara,et al.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.

[37]  A. C. Collins,et al.  Inbred mouse strains vary in oral self-selection of nicotine , 1996, Psychopharmacology.

[38]  P. Blackman.  Actual causes of death in the United States. , 1994, JAMA.

[39]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[40]  H. Ichinose,et al.  Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. , 1992, Biochemistry.

[41]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[42]  A. C. Collins,et al.  Genetic influences on nicotine responses , 1989, Pharmacology Biochemistry and Behavior.

[43]  N. Benowitz.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.

[44]  S. Udenfriend,et al.  On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Franklin,et al.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine , 2005, Psychopharmacology.

[46]  A. C. Collins,et al.  The influence of genotype and sex on behavioral sensitivity to nicotine in mice , 2004, Psychopharmacology.

[47]  Ming D. Li,et al.  A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. , 2003, Addiction.

[48]  Zhaohui S. Qin,et al.  Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[49]  G. Uhl,et al.  The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? , 2002, Addictive behaviors.

[50]  Peter E. Hilsenrath,et al.  The World Health Report 2000 , 2002 .

[51]  Xin Xu,et al.  Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.

[52]  P. Sullivan,et al.  The genetic epidemiology of smoking. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[53]  G. Uhl,et al.  Dopaminergic genes and substance abuse. , 1998, Advances in pharmacology.

[54]  I. Craig,et al.  Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13-->p11 by in situ hybridisation. , 1992, Cytogenetics and cell genetics.